Evaluation of two commercially-available vaccines on in the peripheral lymph nodes of experimentally-infected cattle.

BACKGROUND

is a common inhabitant of the ruminant gastrointestinal tract, where it often resides asymptomatically and may be shed into the feces. More recently it was discovered that may be contained within the peripheral, non-mesenteric lymph nodes, where it is impervious to in-plant pathogen control interventions and may serve as a source of -contamination of ground beef. Over the past 10 years considerable research effort has been expended at understanding how this pathogen gets to these lymph nodes, the duration of infection, and, most importantly, screening and developing potential intervention strategies that may be employed on farm prior to the animal being presented for slaughter.

METHODS

Utilizing an experimental model of inoculation of bovine peripheral lymph nodes (PLNs), two pilot vaccine experiments were conducted to evaluate two vaccines: Newport Bacterial Extract (Experiment I) and Endovac-Bovi (Experiment II) on preventing acquisition by these nodes. In Experiment I, 4 months following the booster vaccination, 30 steers were inoculated with three serotypes intradermally: Newport, Montevideo, and Anatum administered to the right legs, left legs, and to the caudal thorax and abdomen, respectively. Cattle were inoculated every other day over the course of five days (three total inoculation events) and 6 and 12 days following the final inoculation, 16 and 14 head in each treatment were euthanized, respectively. In Experiment II, 12 head of Holstein steers were utilized. Seven days following the booster and weekly thereafter for 3 weeks (four total inoculation events), cattle were inoculated as above and euthanized 7 days following final inoculation. Right and left sub-iliac, popliteal and pre-scapular lymph nodes were collected in each experiment, weighed and cultured for .

RESULTS

In Experiment I, no treatment differences were observed in prevalence 6 days post-inoculation (necropsy 1). However, in vaccinated cattle at the second necropsy, a reduction ( = 0.05) in prevalence was observed in the sub-iliac and pre-scapular lymph nodes as well as when all nodes were evaluated collectively ( = 0.04). In Experiment II, the vaccine reduced ( = 0.03) prevalence in the right popliteal and tended ( = 0.09) to decrease prevalence in both popliteal lymph nodes.

CONCLUSION

Under these experimental conditions, the data generated provide evidence of a partial vaccine effect on within PLNs and indicate that further research may be warranted.